IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.988
AS - Asia 8.079
EU - Europa 5.881
SA - Sud America 1.332
Continente sconosciuto - Info sul continente non disponibili 1.263
AF - Africa 174
OC - Oceania 7
Totale 45.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.635
SG - Singapore 3.653
CN - Cina 1.690
UA - Ucraina 1.380
IT - Italia 1.203
BR - Brasile 1.032
HK - Hong Kong 877
DE - Germania 769
SE - Svezia 654
VN - Vietnam 641
TR - Turchia 489
RU - Federazione Russa 380
FR - Francia 330
IE - Irlanda 280
FI - Finlandia 252
GB - Regno Unito 238
IN - India 166
CA - Canada 135
AR - Argentina 110
BD - Bangladesh 109
NL - Olanda 91
MX - Messico 84
IQ - Iraq 58
JP - Giappone 54
AT - Austria 50
CO - Colombia 50
EC - Ecuador 47
PL - Polonia 45
ZA - Sudafrica 45
BE - Belgio 38
PK - Pakistan 37
ID - Indonesia 34
ES - Italia 33
SA - Arabia Saudita 30
CR - Costa Rica 27
EU - Europa 25
KR - Corea 24
UZ - Uzbekistan 24
VE - Venezuela 24
PH - Filippine 23
CL - Cile 22
JM - Giamaica 22
CZ - Repubblica Ceca 21
KE - Kenya 21
PE - Perù 20
JO - Giordania 19
MA - Marocco 19
IL - Israele 17
MY - Malesia 14
NI - Nicaragua 14
RS - Serbia 14
TH - Thailandia 14
AE - Emirati Arabi Uniti 13
PY - Paraguay 13
TT - Trinidad e Tobago 13
AZ - Azerbaigian 12
EE - Estonia 12
GT - Guatemala 11
IR - Iran 11
LT - Lituania 11
TN - Tunisia 11
BO - Bolivia 10
DZ - Algeria 10
DO - Repubblica Dominicana 9
HN - Honduras 9
KZ - Kazakistan 9
NP - Nepal 9
RO - Romania 9
CH - Svizzera 8
ET - Etiopia 8
GR - Grecia 8
HU - Ungheria 8
AO - Angola 7
DK - Danimarca 7
LV - Lettonia 7
OM - Oman 7
SC - Seychelles 7
SV - El Salvador 7
AM - Armenia 6
EG - Egitto 6
LB - Libano 6
BG - Bulgaria 5
GH - Ghana 5
PA - Panama 5
PR - Porto Rico 5
PT - Portogallo 5
CW - ???statistics.table.value.countryCode.CW??? 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BW - Botswana 3
CY - Cipro 3
GE - Georgia 3
GP - Guadalupe 3
LK - Sri Lanka 3
MM - Myanmar 3
MN - Mongolia 3
Totale 44.418
Salva come PNG Salva come JPEG
Città #
Fairfield 3.666
Woodbridge 3.349
Houston 2.267
Ashburn 2.188
Ann Arbor 1.933
Singapore 1.541
Seattle 1.471
Chandler 1.365
Wilmington 1.314
Cambridge 1.304
Hong Kong 859
San Jose 855
Dearborn 815
Beijing 750
Jacksonville 692
Izmir 453
Boardman 446
Council Bluffs 446
Princeton 302
Dublin 274
Lauterbourg 270
Los Angeles 222
Udine 190
San Diego 177
Des Moines 167
Dong Ket 158
Ho Chi Minh City 158
Dallas 157
Santa Clara 130
Milan 126
Buffalo 118
Redondo Beach 118
Hanoi 110
New York 104
Falls Church 94
São Paulo 90
Andover 74
Frankfurt am Main 68
Hefei 68
Norwalk 67
Rome 64
Munich 63
Nanjing 55
Phoenix 55
Ogden 51
Helsinki 50
The Dalles 49
Chicago 48
Atlanta 47
Tokyo 47
North Bergen 46
Guangzhou 40
Kunming 40
Brooklyn 39
Warsaw 39
Brussels 37
Orem 37
Nuremberg 35
Montreal 34
Rio de Janeiro 34
Shanghai 34
London 32
Redmond 32
Naples 31
Chennai 30
Grafing 30
Trieste 30
Jinan 28
Denver 26
Fuzhou 26
Toronto 26
Turin 26
Baghdad 25
Johannesburg 24
Mexico City 24
Vienna 24
Belo Horizonte 23
Haiphong 23
Bologna 22
Boston 22
San José 22
Mumbai 21
San Francisco 21
Amsterdam 20
Fremont 20
Palermo 20
Quito 20
Stockholm 20
Curitiba 19
Da Nang 19
Tashkent 19
Washington 19
Redwood City 18
Amman 17
Brasília 17
Nanchang 17
Venezia 17
Zhengzhou 17
Brno 16
Buenos Aires 16
Totale 30.779
Salva come PNG Salva come JPEG
Nome #
Terapia e profilassi delle infezioni 523
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 292
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 276
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 259
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 254
The management of multidrug-resistant enterobacteriaceae 252
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 249
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 231
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 231
Delafloxacin for the treatment of respiratory and skin infections 228
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 217
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 217
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 215
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 211
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 205
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 202
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 198
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 197
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 196
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 193
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 192
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 191
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 191
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 189
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 189
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 189
Advances in antibiotic therapy in the critically ill 189
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 188
Safety of long-term use of linezolid: Results of an open-label study 188
New therapeutic options for respiratory tract infections 188
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 188
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 185
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 185
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 185
An Italian consensus for invasive candidiasis management (ITALIC) 185
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 184
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 184
Hot topics in necrotising skin and soft tissue infections 183
Ceftolozane/tazobactam: place in therapy 183
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 183
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 182
Current and future therapies for invasive aspergillosis 182
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 182
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 182
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 182
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 182
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 182
Impact of new treatment options for hepatitis c virus infection in liver transplantation 182
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 181
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 181
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 179
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 179
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 178
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 178
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 178
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 178
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 177
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 176
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 176
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 175
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 175
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 175
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 175
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 175
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 174
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 174
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 174
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 174
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 174
Linezolid underexposure in a patient co-treated with venlafaxine 172
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 172
A survey on infection management practices in Italian ICUs 172
New therapeutic options for skin and soft tissue infections 172
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 172
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 172
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection 172
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation 171
The role of dalbavancin in skin and soft tissue infections 171
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 170
Eravacycline for the treatment of intra-abdominal infections 170
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 169
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 169
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 168
Development of novel antibacterial drugs to combat multiple resistant organisms 168
Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 168
Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital 167
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 167
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 167
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 167
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 166
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study 166
Fungal endogenous endophthalmitis secondary to magnusiomyces capitatus 165
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 165
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 164
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 164
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 163
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal 163
Is MIC increase of meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae correlated with the increase of resistance rates against some other antibiotics with Gram-negative activity? 163
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies 162
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 162
Totale 18.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.397
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.033 0 0 0 0 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20254.553 137 357 226 220 138 259 221 354 565 405 457 1.214
2025/20268.542 646 908 680 665 1.424 888 1.165 304 542 647 433 240
2026/20272.858 268 688 820 1.020 62 0 0 0 0 0 0 0
Totale 45.724